Interestingly, we found that DIM treatment significantly decreased the protein levels of MDM2 in both HCT-116 (p53 wild-type) and HT-29 (p53 mutant) CRC cells, in a dose-dependent manner (Figure 1E). Here, MDM2 is linked to colorectal carcinoma.